The blood transcriptional response in patients developing intensive care unit-acquired pneumonia
Source
The European respiratory journal - ISSN 0903-1936- (2025) p.
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT) : a descriptive, multinational, open-label, phase 3, randomised trial
Source
The lancet infectious diseases - ISSN 1473-3099-25:2 (2025) p. 218-230
Tracing carriage, acquisition, and transmission of ESBL-producing Escherichia coli over two years in a tertiary care hospital
Source
Genome medicine - ISSN 1756-994X-16:1 (2024) p. 1-15
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273 : a randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
Source
International journal of infectious diseases - ISSN 1201-9712-146 (2024) p. 1-11
Long-term effects of ciprofloxacin treatment on the gastrointestinal and oropharyngeal microbiome are more pronounced after longer antibiotic courses
Source
International journal of antimicrobial agents - ISSN 0924-8579-64:3 (2024) p. 1-9